Drug:
Reaction: FALL
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26913220 |
US |
71 | 1 |
Cervical spinal stenosis, Back pain, Gait inability, Dizziness, Musculoskeletal stiffness, Freezing phenomenon, Tremor, Gait disturbance, Dysphonia, Dysphagia, Mastication disorder, Fall, |
||||
FOSCARBIDOPA/FOSLEVODOPA, AMANTADINE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PRAMIPEXOLE DIHYDROCHLORIDE, |
||||
| 402 | 26913229 |
US |
82 | |
Fall, Lower limb fracture, Product dose omission issue, |
||||
VUTRISIRAN, |
||||
| 403 | 26913317 |
US |
74 | 2 |
Malaise, Fall, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 404 | 26913495 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Anxiety, Epilepsy, Ankle fracture, Migraine, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Vomiting, Nausea, Hypertension, Diarrhoea, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Foot fracture, Blood alkaline phosphatase increased, Dizziness, Haematocrit decreased, Haemoglobin decreased, White blood cell count decreased, Malaise, Headache, Abnormal behaviour, Emotional distress, Skin discolouration, Depression, Ligament sprain, Myopia, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Asphyxia, Choking, Petit mal epilepsy, Metastases to lung, Neoplasm malignant, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Depressed mood, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Electric shock sensation, Full blood count decreased, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Pain, Fluid retention, Fat tissue increased, Dry eye, Back pain, Abdominal discomfort, Diarrhoea, Fatigue, Headache, Dysgeusia, Memory impairment, Aversion, Blood sodium increased, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Elliptocytosis, Discomfort, Atrioventricular block first degree, Red cell distribution width increased, Red blood cell sedimentation rate increased, Blood glucose increased, Gastrointestinal disorder, Mean cell volume increased, Rouleaux formation, Limb deformity, Oral herpes, Ill-defined disorder, Thyroid mass, Visual impairment, Decreased immune responsiveness, Neoplasm, Arthritis, Gingival disorder, Pruritus, Hypersensitivity, Pyrexia, Red blood cell count decreased, Lymphocyte count decreased, Dry skin, Pain in extremity, Vision blurred, Herpes virus infection, Viral diarrhoea, Colitis, Chills, Agitation, Confusional state, Oesophagitis, Gastrooesophageal reflux disease, Stress, Catheter site pain, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Weight decreased, Nasopharyngitis, Alopecia, Tension headache, |
||||
LETROZOLE, LETROZOLE, LETROZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, ERGOCALCIFEROL, CALCIUM, |
||||
| 405 | 26913534 |
EU |
66 | 2 |
Dizziness, Balance disorder, Fall, Pain, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 406 | 26914025 |
US |
60 | 1 |
Fall, |
||||
SIBEPRENLIMAB, |
||||
| 407 | 26914279 |
EU |
83 | 1 |
Urinary retention, Fall, Confusional state, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 408 | 26914295 |
US |
2 | |
Syncope, Fall, Cardiac disorder, |
||||
VORASIDENIB, |
||||
| 409 | 26914414 |
US |
70 | 2 |
Loss of consciousness, Fall, Dizziness, Back pain, Insomnia, Hypotension, Nasopharyngitis, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 410 | 26914511 |
EU |
57 | 1 |
Loss of consciousness, General physical health deterioration, Dyskinesia, Malaise, Sitting disability, Musculoskeletal discomfort, Muscle rigidity, Dizziness, Musculoskeletal stiffness, Muscle spasms, Cognitive disorder, Tremor, Hyperventilation, Gait disturbance, Medical device discomfort, Agitation, Hypotension, Fall, Limb injury, Oedema peripheral, On and off phenomenon, Weight decreased, Abnormal dreams, Hand-eye coordination impaired, Neuropathy peripheral, |
||||
| 411 | 26904552 |
US |
2 | |
Pneumonia, Fall, Joint injury, Hospitalisation, Blood pressure increased, Therapy interrupted, Insurance issue, |
||||
VOCLOSPORIN, VOCLOSPORIN, VOCLOSPORIN, |
||||
| 412 | 26904620 |
CA |
74 | 1 |
Arthralgia, Arthritis, Atrial flutter, Back pain, Blood pressure diastolic decreased, Blood pressure systolic increased, Body temperature increased, Cardiac failure congestive, Concomitant disease aggravated, Diabetes mellitus, Eczema, Fall, Fatigue, Gastrooesophageal reflux disease, Herpes zoster, Hyperhidrosis, Hypotension, Malaise, Mitral valve incompetence, Neck pain, Pain, Peripheral swelling, Photosensitivity reaction, Pneumonia, Pyrexia, Weight decreased, Underdose, Abdominal pain, Asthenia, Dehydration, Heart rate increased, Cholelithiasis, Pruritus, Rash, Injection site mass, Product quality issue, Needle issue, Wrong technique in product usage process, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, BISOPROLOL FUMARATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, ACETAMINOPHEN AND CODEINE, APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, NAPROXEN, NAPROXEN SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TESTOSTERONE, VALSARTAN, VALSARTAN ORAL, |
||||
| 413 | 26904694 |
US |
54 | 2 |
Dizziness, Platelet count decreased, Fall, Balance disorder, Muscle twitching, Dysphemia, |
||||
XANOMELINE AND TROSPIUM CHLORIDE, XANOMELINE AND TROSPIUM CHLORIDE, XANOMELINE AND TROSPIUM CHLORIDE, |
||||
| 414 | 26904762 |
US |
63 | 2 |
Dizziness, Nausea, Fall, Vertigo, Diplopia, |
||||
| 415 | 26904810 |
US |
90 | 1 |
Fall, |
||||
BRIVARACETAM, |
||||
| 416 | 26904831 |
US |
75 | 1 |
Head injury, Fall, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, ALBUTEROL SULFATE, ALBUTEROL, CARBIDOPA AND LEVODOPA, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CLONAZEPAM, ENTACAPONE, FLUTICASONE PROPIONATE, FUROSEMIDE, LORATADINE, LORATADINE ORAL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PRAMIPEXOLE, ZALEPLON, BENZONATATE, ERGOCALCIFEROL, MONTELUKAST, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 417 | 26904848 |
US |
2 | |
Circumstance or information capable of leading to medication error, Fall, |
||||
OFATUMUMAB, |
||||
| 418 | 26904910 |
US |
||
Pyoderma gangrenosum, Periprosthetic joint infection, Fall, Injury, |
||||
OLUTASIDENIB, |
||||
| 419 | 26904914 |
US |
2 | |
Fall, Bone cancer metastatic, Fatigue, Nausea, Upper limb fracture, Blood urine present, Stomatitis, Vomiting, |
||||
CABOZANTINIB, LISINOPRIL, MIRABEGRON, PANTOPRAZOLE, |
||||
| 420 | 26904953 |
JP |
10 | 1 |
Femoral neck fracture, Fall, |
||||
PANITUMUMAB, |
||||
| 421 | 26905049 |
CA |
58 | 2 |
Rib fracture, Fall, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 422 | 26905305 |
CA |
80 | 2 |
Blindness transient, Fall, Injury, |
||||
| 423 | 26905483 |
US |
84 | 2 |
Fall, Loss of consciousness, Blindness unilateral, Visual impairment, Cardiac murmur, Hypertension, |
||||
ACALABRUTINIB, CALCIUM, FLUVASTATIN SODIUM, |
||||
| 424 | 26905548 |
US |
84 | 2 |
Fall, Head injury, Musculoskeletal disorder, Urinary tract infection, |
||||
EVOLOCUMAB, |
||||
| 425 | 26905714 |
US |
84 | 2 |
Fall, Dyspnoea, Confusional state, Chest pain, Delirium, Pulmonary oedema, Wheezing, Cough, Asthma, Dyspnoea, Sputum discoloured, Therapy interrupted, Asthenia, Fatigue, Oedema peripheral, Arthritis, Retinal disorder, Generalised oedema, Adverse drug reaction, Insomnia, Stasis dermatitis, |
||||
BENRALIZUMAB, BENRALIZUMAB, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, AMLODIPINE, APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZELASTINE, BACLOFEN, |
||||
| 426 | 26905784 |
CO |
77 | 2 |
Blindness, Deafness, Chest injury, Fall, Viral infection, Back injury, Facial pain, Joint swelling, Influenza, Pain, Arthralgia, Plantar fasciitis, Gastrooesophageal reflux disease, Illness, Abdominal discomfort, Dizziness, Erythema, Burning sensation, Rash, Ocular icterus, Lacrimation increased, Photophobia, Headache, Gingival pain, Amnesia, Alopecia, Odynophagia, Facial asymmetry, Rhinorrhoea, Gait disturbance, Depression, Skin exfoliation, Coordination abnormal, |
||||
DENOSUMAB, |
||||
| 427 | 26905895 |
CO |
87 | 2 |
Fall, Hip fracture, |
||||
DENOSUMAB, |
||||
| 428 | 26905953 |
US |
1 | |
Lower limb fracture, Syncope, Fall, Blood pressure decreased, Balance disorder, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 429 | 26906143 |
US |
65 | 2 |
Fall, Blood sodium decreased, Head injury, |
||||
OSILODROSTAT, OSILODROSTAT, |
||||
| 430 | 26906177 |
GB |
76 | 2 |
Hypervolaemia, Asthenia, Urinary tract infection, Fall, Radius fracture, Product use issue, |
||||
MOMELOTINIB, MOMELOTINIB, HYDROXYUREA, |
||||
| 431 | 26906237 |
CA |
74 | 2 |
Hip fracture, Fractured sacrum, Fall, |
||||
DENOSUMAB, |
||||
| 432 | 26906276 |
GB |
85 | 1 |
Fall, Lower limb fracture, |
||||
USTEKINUMAB, |
||||
| 433 | 26906368 |
US |
54 | 1 |
Immune-mediated myositis, Respiratory failure, Fall, |
||||
APIXABAN, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 434 | 26906400 |
GB |
62 | 2 |
Fall, Hip fracture, Lower respiratory tract infection, |
||||
UPADACITINIB, |
||||
| 435 | 26906500 |
CO |
77 | 2 |
Memory impairment, COVID-19, Headache, Anxiety, Blister, Gastroenteritis viral, Psychiatric symptom, Pruritus, Urticaria, Illness, Bone disorder, Malaise, Cough, Gastrooesophageal reflux disease, Fall, Gait disturbance, Erythema, Dry skin, Angioedema, Swelling face, Peripheral swelling, Dyspnoea, Fatigue, Back pain, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FEXOFENADINE, |
||||
| 436 | 26906571 |
US |
41 | 2 |
Cardiac flutter, Speech disorder, Anxiety, Insomnia, Panic attack, Feeling abnormal, Headache, Palpitations, Dysarthria, Dysphemia, Aphasia, Fall, Product quality issue, |
||||
| 437 | 26906586 |
EU |
89 | 2 |
Haematoma, Fall, Chest injury, |
||||
| 438 | 26906591 |
EU |
81 | 2 |
Cardiac failure, Constipation, Weight increased, Dizziness, Somnolence, Asthenia, Abdominal pain upper, Fall, Dehydration, Dyspnoea, Speech disorder, |
||||
RIVASTIGMINE, GALANTAMINE HYDROBROMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, APIXABAN, RAMIPRIL, CALCIUM ACETATE, |
||||
| 439 | 26906708 |
US |
72 | 2 |
Fall, |
||||
DUPILUMAB, |
||||
| 440 | 26907229 |
4 | 2 | |
Fall, Compression fracture, Osteoporosis, Thoracic vertebral fracture, Thoracic vertebral fracture, Thoracic vertebral fracture, Thoracic vertebral fracture, Off label use, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METHOTREXATE, METHOTREXATE SODIUM, MEDROXYPROGESTERONE ACETATE, RITUXIMAB, HYDROXYCHLOROQUINE, |
||||
| 441 | 26907495 |
IN |
2 | |
Cardio-respiratory arrest, Femur fracture, Fall, |
||||
OSIMERTINIB, |
||||
| 442 | 26907554 |
US |
82 | 2 |
Compression fracture, Fall, Asthenia, Back pain, Fatigue, Clumsiness, Memory impairment, Hepatic enzyme increased, |
||||
DENOSUMAB, IBANDRONATE SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CITALOPRAM, CITALOPRAM HYDROBROMIDE, BETAMETHASONE DIPROPIONATE, LATANOPROST, LOSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, VITAMIN C, |
||||
| 443 | 26907796 |
US |
55 | 1 |
Foot fracture, Upper limb fracture, Fall, Fall, |
||||
RISANKIZUMAB-RZAA, |
||||
| 444 | 26907977 |
CA |
64 | 2 |
Fall, Rib fracture, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 445 | 26908138 |
US |
13 | 1 |
Head injury, Fall, |
||||
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, |
||||
| 446 | 26908172 |
CN |
62 | 1 |
Upper gastrointestinal haemorrhage, Fall, Gastritis erosive, Chronic gastritis, Haematemesis, Abdominal distension, Anaemia, Melaena, Discoloured vomit, Gastric ulcer, Syncope, Dizziness, Faeces discoloured, Diarrhoea, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 447 | 26908182 |
US |
72 | 2 |
Muscular weakness, Fall, Dyspnoea, Dysphagia, |
||||
RAVULIZUMAB, |
||||
| 448 | 26908251 |
30 | ||
Osteoporosis, Fall, Compression fracture, Thoracic vertebral fracture, |
||||
MEDROXYPROGESTERONE ACETATE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RITUXIMAB, HYDROXYCHLOROQUINE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 449 | 26908256 |
54 | ||
Immune-mediated myositis, Respiratory failure, Fall, |
||||
APIXABAN, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 450 | 26908298 |
EU |
79 | 2 |
Off label use, Traumatic intracranial haemorrhage, Fall, |
||||
EMICIZUMAB, EMICIZUMAB, EMICIZUMAB, EMICIZUMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 451 | 26908352 |
US |
75 | |
Hallucination, Peripheral swelling, Constipation, Fall, Product dose omission issue, |
||||
LEVODOPA, LEVODOPA, LEVODOPA, ALPRAZOLAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, CLONAZEPAM, CARBIDOPA AND LEVODOPA, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FISH OIL, FOLIC ACID, AMANTADINE, MAGNESIUM, METHOTREXATE, METHOTREXATE SODIUM, MIRTAZAPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, RASAGILINE MESYLATE, RASAGILINE, CARBIDOPA AND LEVODOPA, ASCORBIC ACID, ERGOCALCIFEROL, RIVAROXABAN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 452 | 26908353 |
CA |
40 | 2 |
Lower respiratory tract infection, Folliculitis, Musculoskeletal pain, Abdominal discomfort, Fall, Muscle injury, Diarrhoea, Hypotension, Gastrooesophageal reflux disease, Nausea, Urticaria, Wound, Rash, Mobility decreased, Night sweats, Breast cancer stage III, Drug-induced liver injury, Muscular weakness, Type 2 diabetes mellitus, Impaired healing, Asthenia, Peripheral swelling, Wheezing, Onychomycosis, Pain in extremity, Glossodynia, Finger deformity, Epilepsy, Obesity, Lip dry, Wound infection, Paraesthesia, Fatigue, Facet joint syndrome, Confusional state, Joint range of motion decreased, Musculoskeletal stiffness, Memory impairment, Muscle spasms, Inflammation, Pain, Headache, Condition aggravated, Dizziness, General physical health deterioration, Blepharospasm, Liver injury, Swelling, Lung disorder, Abdominal pain upper, |
||||
SECUKINUMAB, SECUKINUMAB, ERENUMAB-AOOE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LAMOTRIGINE, LAMOTRIGINE, MEPOLIZUMAB, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TRAMADOL HYDROCHLORIDE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, NAPROXEN, NAPROXEN SODIUM, |
||||
| 453 | 26908452 |
EU |
2 | |
Fall, Off label use, |
||||
ONABOTULINUMTOXINA, |
||||
| 454 | 26908533 |
US |
68 | 2 |
Petit mal epilepsy, Choking, Condition aggravated, Asthenia, Dysarthria, Symptom recurrence, Dysarthria, Dysphonia, Asthenia, Skin laceration, Fall, Insomnia, Skin laceration, Brain fog, Chest discomfort, Muscular weakness, Stress, Impaired quality of life, Abdominal pain upper, Oesophageal pain, Mobility decreased, Dysphagia, Emergency care, Loss of personal independence in daily activities, Fatigue, Chest pain, Myalgia, Injection site bruising, Injection site haemorrhage, Therapeutic response shortened, Therapeutic product effect incomplete, |
||||
EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT), EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT), METHADONE, TOPIRAMATE, PREDNISONE, |
||||
| 455 | 26908709 |
US |
84 | 1 |
Fall, Shoulder fracture, Neuropathy peripheral, |
||||
ZILUCOPLAN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, GABAPENTIN, VALACYCLOVIR HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, VITAMIN E, VITAMIN C, ERGOCALCIFEROL, ZILUCOPLAN, BUPRENORPHINE, POTASSIUM PHOSPHATE, |
||||
| 456 | 26908725 |
US |
2 | |
Fall, Decreased appetite, Somnolence, Vomiting, Abdominal pain, Diarrhoea, Asthenia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 457 | 26908744 |
US |
51 | 2 |
Femur fracture, Lower limb fracture, Fall, |
||||
UPADACITINIB, |
||||
| 458 | 26908829 |
US |
28 | 1 |
Head injury, Fall, Haemorrhage, |
||||
| 459 | 26908834 |
US |
43 | 1 |
Fall, Arthralgia, Pain in extremity, |
||||
AVALGLUCOSIDASE ALFA-NGPT, EPINEPHRINE, ADRENALINUM, WATER, STERILE WATER, STERILE WATER FOR INJECTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, NALOXONE, POLYETHYLENE GLYCOL, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 460 | 26908888 |
US |
81 | 2 |
Ankle fracture, Fall, Hypoaesthesia, Peripheral swelling, Psoriasis, Inappropriate schedule of product administration, |
||||
RISANKIZUMAB-RZAA, |
||||
| 461 | 26909006 |
2 | ||
Pelvic fracture, Fall, Product use issue, Product use in unapproved indication, |
||||
TENAPANOR HYDROCHLORIDE, |
||||
| 462 | 26909241 |
US |
80 | 2 |
Fall, Tibia fracture, Pneumonia, Weight decreased, Pain, Vomiting, Drug ineffective, Constipation, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 463 | 26909372 |
US |
66 | 1 |
Hallucination, visual, Product dose omission issue, Off label use, Drug ineffective, Infusion site mass, Infusion site nodule, Injection site reaction, Fall, Dehydration, Decreased appetite, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, RASAGILINE MESYLATE, MIDODRINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, NORTRIPTYLINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, NALOXONE HYDROCHLORIDE, NALOXONE, NALXONE HYDROCHLORIDE, FINASTERIDE, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, |
||||
| 464 | 26909417 |
CA |
70 | |
Fall, Dementia Alzheimer^s type, Frequent bowel movements, Diarrhoea, |
||||
INFLIXIMAB-DYYB, |
||||
| 465 | 26909474 |
EU |
59 | 1 |
Pelvic fracture, Fall, Mobility decreased, On and off phenomenon, Tension, Dyskinesia, Device information output issue, |
||||
FOSCARBIDOPA/FOSLEVODOPA, CARBIDOPA AND LEVODOPA, RASAGILINE MESYLATE, RASAGILINE, |
||||
| 466 | 26912051 |
79 | 2 | |
Fall, Drug effect less than expected, |
||||
DALFAMPRIDINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FISH OIL, MAGNESIUM, LEVOCARNITINE, LEVOCARNITINE ORAL, VALSARTAN AND HYDROCHLOROTHIAZIDE, |
||||
| 467 | 26918761 |
42 | 2 | |
Fall, Haematoma, Blood pressure decreased, |
||||
ETANERCEPT, |
||||
| 468 | 26918771 |
79 | 2 | |
Clostridium difficile infection, Diarrhoea, Abdominal pain upper, Fall, |
||||
NINTEDANIB, |
||||
| 469 | 26918860 |
63 | 2 | |
Urinary tract infection, Symptom recurrence, Fall, Back pain, |
||||
TERIFLUNOMIDE, |
||||
| 470 | 26903749 |
US |
30 | 2 |
COVID-19, Constipation, Restless legs syndrome, Gastrooesophageal reflux disease, Nausea, Fall, Urinary tract infection, Sciatica, Blood pressure increased, Morning sickness, Exposure during pregnancy, |
||||
BELIMUMAB, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FOLIC ACID, HYDROXYCHLOROQUINE, SUMATRIPTAN, |
||||
| 471 | 26904133 |
US |
||
Fall, Trichosporon infection, Muscular weakness, Urinary retention, |
||||
MORPHINE, |
||||
| 472 | 26904400 |
EU |
80 | 2 |
Joint dislocation, Speech disorder, Musculoskeletal stiffness, Device issue, Device leakage, Gait disturbance, Pain in extremity, Fall, Asthenia, Foot deformity, |
||||
| 473 | 26904489 |
CA |
40 | 2 |
Lower respiratory tract infection, Folliculitis, Musculoskeletal pain, Abdominal discomfort, Fall, Muscle injury, Diarrhoea, Hypotension, Gastrooesophageal reflux disease, Nausea, Urticaria, Wound, Rash, Mobility decreased, Night sweats, Breast cancer stage III, Drug-induced liver injury, Muscular weakness, Type 2 diabetes mellitus, Impaired healing, Asthenia, Peripheral swelling, Wheezing, Onychomycosis, Pain in extremity, Glossodynia, Finger deformity, Epilepsy, Obesity, Lip dry, Wound infection, Paraesthesia, Fatigue, Facet joint syndrome, Confusional state, Joint range of motion decreased, Musculoskeletal stiffness, Memory impairment, Muscle spasms, Inflammation, Pain, Headache, Condition aggravated, Dizziness, General physical health deterioration, Blepharospasm, Liver injury, Swelling, Lung disorder, Abdominal pain upper, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LAMOTRIGINE, LAMOTRIGINE, MEPOLIZUMAB, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, NAPROXEN, NAPROXEN SODIUM, |
||||
| 474 | 26908675 |
70 | 2 | |
Weight decreased, Sleep disorder, Fall, Epistaxis, Acidosis, Vomiting, Cardio-respiratory arrest, |
||||
AMLODIPINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 475 | 26918237 |
69 | 1 | |
Therapy interrupted, Fall, Joint injury, Neck injury, |
||||
TAFAMIDIS, |
||||
| 476 | 26902642 |
US |
47 | 1 |
Cerebral haemorrhage, Fall, Hypoaesthesia, |
||||
RISANKIZUMAB-RZAA, |
||||
| 477 | 26902646 |
EU |
63 | 2 |
Spinal column injury, Fall, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ENALAPRIL, INDAPAMIDE, |
||||
| 478 | 26902699 |
US |
2 | |
Fall, Amnesia, |
||||
PANCRELIPASE, |
||||
| 479 | 26902765 |
EU |
88 | 1 |
Head injury, Fall, Balance disorder, Intentional overdose, Drug abuse, Face injury, Restlessness, Drug interaction, Labelled drug-drug interaction medication error, Drug level increased, Intentional product misuse, Contraindicated product administered, |
||||
ALLOPURINOL, BISOPROLOL FUMARATE, FUROSEMIDE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLARITHROMYCIN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SACCHAROMYCES CEREVISIAE, |
||||
| 480 | 26902784 |
US |
1 | |
Fall, |
||||
TREPROSTINIL, TREPROSTINIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FISH OIL, ISOSORBIDE DINITRATE, FLUTICASONE PROPIONATE AND SALMETEROL, INSULIN GLARGINE, FINASTERIDE, NINTEDANIB, MELATONIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OXYGEN, 0XYGEN, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, |
||||
| 481 | 26903007 |
US |
2 | |
Incorrect dose administered, Pneumonia, Pulmonary mass, Pain, Feeling abnormal, Fall, Amnesia, Blood sodium decreased, Musculoskeletal stiffness, Hyperhidrosis, Tremor, Pain in extremity, Cough, Neck pain, Arthralgia, Decreased appetite, Nausea, Cortisol decreased, Dizziness, Presyncope, Nausea, |
||||
OSILODROSTAT, OSILODROSTAT, OSILODROSTAT, OSILODROSTAT, OSILODROSTAT, MIFEPRISTONE, MIFEPRISTONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 482 | 26903063 |
US |
69 | 2 |
Fall, |
||||
DUPILUMAB, |
||||
| 483 | 26903421 |
CA |
33 | 1 |
Encephalopathy, Condition aggravated, Fall, Drug ineffective, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, TOCILIZUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, BACLOFEN, BRIMONIDINE TARTRATE AND TIMOLOL MALEATE, PREDNISONE, ERGOCALCIFEROL, |
||||
| 484 | 26903627 |
EU |
29 | 1 |
Acute respiratory failure, Fall, Intentional overdose, Drug abuse, |
||||
GABAPENTIN, CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE, OXCARBAZEPINE, OXCARBAZEPINE, |
||||
| 485 | 26897605 |
US |
75 | 1 |
Fall, Cerebral haemorrhage, |
||||
LINAGLIPTIN, ATORVASTATIN CALCIUM, GLIPIZIDE, ERGOCALCIFEROL, FOLIC ACID, FERROUS SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, |
||||
| 486 | 26897617 |
GB |
2 | |
Joint dislocation, Fall, |
||||
RISANKIZUMAB-RZAA, |
||||
| 487 | 26897667 |
US |
66 | 1 |
Haemorrhage intracranial, Fall, |
||||
OLAPARIB, |
||||
| 488 | 26897810 |
IL |
87 | 2 |
Hip fracture, Fall, Therapy non-responder, |
||||
DENOSUMAB, |
||||
| 489 | 26897832 |
CO |
77 | 2 |
Upper limb fracture, Joint injury, Head injury, Fall, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 490 | 26897851 |
JP |
85 | 2 |
Fall, Fracture, |
||||
MEPOLIZUMAB, |
||||
| 491 | 26897888 |
US |
1 | |
Skin cancer, Squamous cell carcinoma, Precancerous condition, Thrombosis, Pulmonary embolism, Oesophageal stenosis, Barrett^s oesophagus, Mental impairment, Haemorrhage, Dry mouth, Skin infection, Pain, Diarrhoea, Dry throat, Dyspnoea exertional, Vomiting, Mobility decreased, Confusional state, Dyspnoea, Feeling abnormal, Arthropathy, Fatigue, Nausea, Arthralgia, Blood glucose abnormal, Breakthrough pain, Abdominal distension, Peripheral swelling, Tooth fracture, Pruritus, Hyperreflexia, Paraesthesia, Epistaxis, Skin ulcer, Musculoskeletal stiffness, Eating disorder, Early satiety, Pain of skin, Tooth disorder, Sensitive skin, Oral candidiasis, Dry eye, Oliguria, Mental status changes, Restless legs syndrome, Muscle twitching, Ocular hyperaemia, Weight increased, Contusion, Dizziness, Blood pressure increased, Headache, Feeling hot, Anxiety, Dysphagia, Full blood count abnormal, Myalgia, Abdominal discomfort, Depression, Polyp, Rib fracture, Memory impairment, Fall, Bone pain, Cystic lung disease, Aggression, Platelet count increased, Malaise, Insomnia, Irritability, Oral discomfort, Pulmonary mass, Hyperhidrosis, Vitamin D decreased, Skin exfoliation, Gastrooesophageal reflux disease, Balance disorder, Pigmentation disorder, Skin burning sensation, Tremor, Nervousness, Weight decreased, Dry skin, Impaired healing, Product dose omission issue, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, AMOXICILLIN, HYDROXYUREA, CLOPIDOGREL, CLOPIDOGREL BISULFATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, MORPHINE SULFATE, RIVAROXABAN, METHOCARBAMOL, METHOCARBAMOL TABLETS, ALPRAZOLAM, SUCRALFATE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, FOLIC ACID, MIRTAZAPINE, CLONAZEPAM, ERGOCALCIFEROL, BUPROPION, ERGOCALCIFEROL, GABAPENTIN, OXYCODONE HYDROCHLORIDE, TETRAHYDROZOLINE HYDROCHLORIDE, CYCLOSPORINE, |
||||
| 492 | 26898101 |
US |
68 | 1 |
Fall, Hallucination, Condition aggravated, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 493 | 26898408 |
76 | 2 | |
Hip fracture, Gait disturbance, Fall, Product dose omission issue, |
||||
LENALIDOMIDE, |
||||
| 494 | 26898503 |
US |
70 | 2 |
Cerebrovascular accident, Fracture, Trichiasis, Visual impairment, Fall, Pain, Off label use, |
||||
TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, |
||||
| 495 | 26898551 |
74 | 2 | |
Fall, Somnolence, |
||||
| 496 | 26898650 |
US |
75 | 2 |
Hip fracture, Peripheral swelling, Pruritus, Fall, Gait disturbance, |
||||
RISANKIZUMAB-RZAA, |
||||
| 497 | 26898718 |
US |
82 | 2 |
Haematoma, Fall, |
||||
DUPILUMAB, CEPHALEXIN, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, FLECAINIDE ACETATE TABLET, FLECAINIDE ACETATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OLMESARTAN MEDOXOMIL, PREDNISONE, ROSUVASTATIN CALCIUM, SPIRONOLACTONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 498 | 26898836 |
US |
73 | 1 |
Fall, |
||||
RELUGOLIX, RELUGOLIX, DAROLUTAMIDE, OXYCODONE, PANTOPRAZOLE, |
||||
| 499 | 26898982 |
CA |
67 | 2 |
Hip fracture, Fall, Ill-defined disorder, |
||||
DENOSUMAB, |
||||
| 500 | 26899097 |
US |
1 | |
Fall, Dizziness, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
